Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

48 Audit on the Management of Patients Admitted with Acute Gallstone Disease

View through CrossRef
Abstract Aim To quantify the proportion of eligible patients admitted with acute gallstone disease receiving a cholecystectomy within 8 days at our hospital, using Chole-QuIC’s methodology. Method A retrospective audit was conducted on all patients admitted with acute gallstone disease to our district general hospital between 01/08/24-31/10/24 (n=119). Hot cholecystectomy candidates were identified using Chole-QuIC’s methodology. Additional data was collected for: surgery waiting times, starvation time (nil by mouth, NBM), length of stay, investigations and interventions. Data was analysed using GraphPad Prism. Results Out of 119 patients, 71.4% and 57.1% underwent CT and ultrasound scans respectively. 77/119 (64.7%) were acute cholecystitis (AC) patients, 7 of whom had percutaneous cholecystostomies. 40 AC patients were fit surgical candidates. 25/40 had inpatient cholecystectomies whilst 15 were discharged with outpatient cholecystectomies. AC patients with inpatient cholecystectomies had lower median surgery waiting times (3 vs 31 days, p< 0.0001). 5/15 discharged AC patients were re-admitted within 30-days. Median NBM days in AC patients was slightly higher in the inpatient cholecystectomies cohort compared to those discharged with outpatient cholecystectomies (2 vs 1 day, p=0.0204). Median admission length was higher in AC patients who had inpatient cholecystectomies (5 vs 3 days, p< 0.0071). Overall, 31/53 (58.5%) eligible acute gallstone disease patients received a cholecystectomy within 8 days. Conclusions There are significant challenges to meet the 8-day surgery rate of 80% targeted by Chole-QuIC in our unit. Inpatient cholecystectomies in the AC patients reduced surgery waiting times and prevented re-admissions but had drawbacks including longer fasting and admission duration.
Title: 48 Audit on the Management of Patients Admitted with Acute Gallstone Disease
Description:
Abstract Aim To quantify the proportion of eligible patients admitted with acute gallstone disease receiving a cholecystectomy within 8 days at our hospital, using Chole-QuIC’s methodology.
Method A retrospective audit was conducted on all patients admitted with acute gallstone disease to our district general hospital between 01/08/24-31/10/24 (n=119).
Hot cholecystectomy candidates were identified using Chole-QuIC’s methodology.
Additional data was collected for: surgery waiting times, starvation time (nil by mouth, NBM), length of stay, investigations and interventions.
Data was analysed using GraphPad Prism.
Results Out of 119 patients, 71.
4% and 57.
1% underwent CT and ultrasound scans respectively.
77/119 (64.
7%) were acute cholecystitis (AC) patients, 7 of whom had percutaneous cholecystostomies.
40 AC patients were fit surgical candidates.
25/40 had inpatient cholecystectomies whilst 15 were discharged with outpatient cholecystectomies.
AC patients with inpatient cholecystectomies had lower median surgery waiting times (3 vs 31 days, p< 0.
0001).
5/15 discharged AC patients were re-admitted within 30-days.
Median NBM days in AC patients was slightly higher in the inpatient cholecystectomies cohort compared to those discharged with outpatient cholecystectomies (2 vs 1 day, p=0.
0204).
Median admission length was higher in AC patients who had inpatient cholecystectomies (5 vs 3 days, p< 0.
0071).
Overall, 31/53 (58.
5%) eligible acute gallstone disease patients received a cholecystectomy within 8 days.
Conclusions There are significant challenges to meet the 8-day surgery rate of 80% targeted by Chole-QuIC in our unit.
Inpatient cholecystectomies in the AC patients reduced surgery waiting times and prevented re-admissions but had drawbacks including longer fasting and admission duration.

Related Results

Paper K-9 Pelaporan Hasil Audit dan Tindak Lanjut Audit Internal
Paper K-9 Pelaporan Hasil Audit dan Tindak Lanjut Audit Internal
Pelaporan hasil audit merupakan komponen utama dalam komunikasi dari audit internal tentang hasil audit. Untuk mengkomunikasikan hasil audit diperlukan susunan laporan, dimana hasi...
EGS P16 Management of Acute Gallstone disease at an urban acute Trust during the pandemic
EGS P16 Management of Acute Gallstone disease at an urban acute Trust during the pandemic
Abstract Background Acute gallstone disease is a surgical emergency. Management has evolved over the years with emphasis on earl...
DETERMINAN FEE AUDIT
DETERMINAN FEE AUDIT
ABSTRACT This study aims to examine the factors that affect audit fees. Factors examined include  factors derived from the entity (client) and the factors derived from the auditor....
Current Management of Acute Gallstone Pancreatitis: Narrative Review Article
Current Management of Acute Gallstone Pancreatitis: Narrative Review Article
Acute gallstone pancreatitis is the most common cause of acute pancreatitis, and it is divided into mild and severe forms. The management of acute gallstone pancreatitis will initi...
Pengaruh Audit Tenure, Auditor Switching, dan Opini Audit terhadap Audit Delay
Pengaruh Audit Tenure, Auditor Switching, dan Opini Audit terhadap Audit Delay
Although it is required for go-public companies to report their audited financial statements, some companies do not fulfill their responsibility in a timely manner. This study aims...
Abnormal audit fees and accrual and real earnings management: evidence from UK
Abnormal audit fees and accrual and real earnings management: evidence from UK
Purpose This paper aims to examine the relationship between abnormal audit fees and accrual-based and real-based earnings management by using a sample of 1,055 UK...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

Back to Top